CISCRP and Oxford PharmaGenesis expand community clinical research outreach

CISCRP has formed a new community education and outreach partnership with Oxford PharmaGenesis to help build clinical research literacy and trust, with support flowing to two of CISCRP’s core engagement programs. The collaboration comes as CISCRP prepares for more 2026 events and a 2027 calendar expected to reach thousands of people across the U.S.

Why it matters: - The partnership is aimed at making clinical research easier to understand for communities that are often underrepresented in trials. - CISCRP said the support will help sustain outreach efforts that break down participation barriers and strengthen public trust in clinical research. - The work is focused on health literacy, which can affect whether patients feel informed enough to consider a clinical trial.

What happened: - CISCRP announced a community education and outreach partnership with Oxford PharmaGenesis. - Oxford PharmaGenesis is a global HealthScience communications consultancy and part of the Klick Health family. - The partnership supports CISCRP’s Community Engagement Programs. - The announcement was made Oct. 14, 2026.

The details: - The support will sustain two CISCRP initiatives: AWARE for All and the Journey to Better Health Mobile Exhibit. - AWARE for All works with local advocacy and healthcare groups across the U.S. to share clinical research information, provide resources and offer free health screenings at health fairs, expos and cultural festivals. - The Journey to Better Health Mobile Exhibit is an interactive traveling classroom that brings the clinical research process into neighborhoods. - Oxford PharmaGenesis said it is focused on advancing clinical research education and health literacy where they are needed most. - Behtash Bahador, senior director of community engagement and partnerships at CISCRP, said the partnership helps bring clinical research education directly to underserved communities. - Richard White, president of HealthScience Communications at Oxford PharmaGenesis, said the goal is to help bring life-changing treatments to patients by communicating medical science clearly and with integrity. - Chris Winchester, head of scientific affairs at Oxford PharmaGenesis, said the company is continuing its relationship with CISCRP to advance inclusivity in clinical research and better reflect wider communities in trial populations. - CISCRP said its 2027 event calendar is expected to mirror the reach of its 2026 tour. - CISCRP expects more than 4,500 community members to be engaged face-to-face across more than 25 events in 15-plus cities, major metro areas and community hubs in the U.S.

Between the lines: - The partnership pairs a patient-facing nonprofit with a communications firm that works in health science, a combination that can translate complex research topics into plain language for the public. - The emphasis on underserved communities and representative trial populations signals a push to improve who gets reached, informed and potentially enrolled in studies. - The event-heavy strategy suggests CISCRP is still relying on in-person outreach as a primary tool for trust-building.

What's next: - CISCRP said remaining 2026 events include stops in Aurora, Colorado; Sioux Falls, South Dakota; Charlotte, North Carolina; Chicago; Birmingham, Alabama; and Rosenberg, Texas. - Upcoming events listed include Rare Disease Fair, Health Connect Festival, Black Health Matters, Latina’s Expo, Black Men’s Wellness Day, Magic City Wellness Pop Up, Magic City Classic and the 2026 Star Veterans & Senior Resource Expo. - More information is available at CISCRP’s Community Engagement Programs.

The bottom line: - CISCRP is expanding a hands-on public education model for clinical research, with Oxford PharmaGenesis helping fund and reinforce outreach designed to build trust, awareness and participation.